Free Trial

Firefly Neuroscience Q2 2024 Earnings Report

Firefly Neuroscience logo
$3.48 +0.01 (+0.29%)
As of 04:00 PM Eastern

Firefly Neuroscience EPS Results

Actual EPS
-$0.58
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Firefly Neuroscience Revenue Results

Actual Revenue
$1.90 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Firefly Neuroscience Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Firefly Neuroscience Earnings Headlines

Firefly Neuroscience announces publications on EEG analytics
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
This Micro Cap Soared On Key Announcement
See More Firefly Neuroscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Firefly Neuroscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Firefly Neuroscience and other key companies, straight to your email.

About Firefly Neuroscience

Firefly Neuroscience (NASDAQ:AIFF), a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

View Firefly Neuroscience Profile

More Earnings Resources from MarketBeat